Literature DB >> 23845298

Factors influencing relative speech intelligibility in patients with oral squamous cell carcinoma: a prospective study using automatic, computer-based speech analysis.

F Stelzle1, C Knipfer, M Schuster, T Bocklet, E Nöth, W Adler, L Schempf, P Vieler, M Riemann, F W Neukam, E Nkenke.   

Abstract

Oral squamous cell carcinoma (OSCC) and its treatment impair speech intelligibility by alteration of the vocal tract. The aim of this study was to identify the factors of oral cancer treatment that influence speech intelligibility by means of an automatic, standardized speech-recognition system. The study group comprised 71 patients (mean age 59.89, range 35-82 years) with OSCC ranging from stage T1 to T4 (TNM staging). Tumours were located on the tongue (n=23), lower alveolar crest (n=27), and floor of the mouth (n=21). Reconstruction was conducted through local tissue plasty or microvascular transplants. Adjuvant radiotherapy was performed in 49 patients. Speech intelligibility was evaluated before, and at 3, 6, and 12 months after tumour resection, and compared to that of a healthy control group (n=40). Postoperatively, significant influences on speech intelligibility were tumour localization (P=0.010) and resection volume (P=0.019). Additionally, adjuvant radiotherapy (P=0.049) influenced intelligibility at 3 months after surgery. At 6 months after surgery, influences were resection volume (P=0.028) and adjuvant radiotherapy (P=0.034). The influence of tumour localization (P=0.001) and adjuvant radiotherapy (P=0.022) persisted after 12 months. Tumour localization, resection volume, and radiotherapy are crucial factors for speech intelligibility. Radiotherapy significantly impaired word recognition rate (WR) values with a progression of the impairment for up to 12 months after surgery.
Copyright © 2013 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  automatic speech recognition; functional rehabilitation; objective speech assessment; oral carcinoma; outcome analysis; perceptual evaluation; speech intelligibility; squamous cell carcinoma

Mesh:

Year:  2013        PMID: 23845298     DOI: 10.1016/j.ijom.2013.05.021

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  9 in total

1.  Primary radical ablative surgery and fibula free-flap reconstruction for T4 oral cavity squamous cell carcinoma with mandibular invasion: oncologic and functional results and their predictive factors.

Authors:  Olivier Camuzard; Olivier Dassonville; Marc Ettaiche; Emmanuel Chamorey; Gilles Poissonnet; Riadh Berguiga; Axel Leysalle; Karen Benezery; Frédéric Peyrade; Esma Saada; Raphael Hechema; Anne Sudaka; Juliette Haudebourg; François Demard; José Santini; Alexandre Bozec
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-07-20       Impact factor: 2.503

2.  Radiation Therapy Reduced Blood Levels of LDH, HIF-1α, and miR-210 in OSCC.

Authors:  Marcela Gonçalves de Souza; Sabrina Ferreira de Jesus; Eloá Mangabeira Santos; Emisael Stenio Batista Gomes; Arlen de Paulo Santiago Filho; Eliane Macedo Sobrinho Santos; Luiz Henrique da Silveira; Sérgio Henrique Sousa Santos; Alfredo Maurício Batista de Paula; Lucyana Conceição Farias; André Luiz Sena Guimarães
Journal:  Pathol Oncol Res       Date:  2018-11-08       Impact factor: 3.201

3.  Treatment of mucositis with combined 660- and 808-nm-wavelength low-level laser therapy reduced mucositis grade, pain, and use of analgesics: a parallel, single-blind, two-arm controlled study.

Authors:  Raquel Gusmão Soares; Lucyana Conceição Farias; Agna Soares da Silva Menezes; Carla Silvana de Oliveira E Silva; Angeliny Tamiarana Lima Tabosa; Pablo Vinicyus Ferreira Chagas; Laís Santiago; Sérgio Henrique Sousa Santos; Alfredo Maurício Batista de Paula; André Luiz Sena Guimarães
Journal:  Lasers Med Sci       Date:  2018-06-15       Impact factor: 3.161

4.  The (head and neck) carcinologic handicap index: validation of a modular type questionnaire and its ability to prioritise patients' needs.

Authors:  Mathieu Balaguer; Maëlle Champenois; Jérôme Farinas; Julien Pinquier; Virginie Woisard
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-07-14       Impact factor: 2.503

5.  Factors influencing intelligibility and severity of chronic speech disorders of patients treated for oral or oropharyngeal cancer.

Authors:  Mathieu Balaguer; Aline Boisguerin; Anaïs Galtier; Nadège Gaillard; Michèle Puech; Virginie Woisard
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-03-27       Impact factor: 2.503

6.  Data mining of an acoustic biomarker in tongue cancers and its clinical validation.

Authors:  Yudong Xiao; Tao Wang; Wei Deng; Le Yang; Bin Zeng; Xiaomei Lao; Sien Zhang; Xiangqi Liu; Daiqiao Ouyang; Guiqing Liao; Yujie Liang
Journal:  Cancer Med       Date:  2021-05-02       Impact factor: 4.452

7.  Speaking legibly: Qualitative perceptions of altered voice among oral tongue cancer survivors.

Authors:  Genevieve Philiponis; Sarah H Kagan
Journal:  Asia Pac J Oncol Nurs       Date:  2015 Oct-Dec

8.  Regular Dental Visits: Influence on Health-Related Quality of Life in 1,607 Patients with Oral Squamous Cell Carcinoma.

Authors:  Simon Spalthoff; Henrik Holtmann; Gertrud Krüskemper; Rüdiger Zimmerer; Jörg Handschel; Nils-Claudius Gellrich; Philipp Jehn
Journal:  Int J Dent       Date:  2017-05-30

9.  Metformin increases PDH and suppresses HIF-1α under hypoxic conditions and induces cell death in oral squamous cell carcinoma.

Authors:  Talita Antunes Guimarães; Lucyana Conceição Farias; Eliane Sobrinho Santos; Carlos Alberto de Carvalho Fraga; Lissur Azevedo Orsini; Leandro de Freitas Teles; John David Feltenberger; Sabrin Ferreira de Jesus; Marcela Gonçalves de Souza; Sérgio Henrique Sousa Santos; Alfredo Maurício Batista de Paula; Ricardo Santiago Gomez; André Luiz Sena Guimarães
Journal:  Oncotarget       Date:  2016-08-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.